Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
PABPN1 is an abundant nuclear protein that binds to the poly(A) tails of nascent mRNA molecules, playing a crucial role in polyadenylation, mRNA stability, and export. It is also involved in alternative polyadenylation and the regulation of long noncoding RNAs. Expansion mutations in the polyalanine tract of PABPN1 cause oculopharyngeal muscular dystrophy (OPMD).
Not applicable, this is not a drug.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Polyadenylate-binding nuclear protein 1 (PABPN1).